COMMUNIQUÉS West-GlobeNewswire

-
GUERBET : 2024 full-year results.
26/03/2025 -
Trading by management and close relations of management
26/03/2025 -
RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) demonstrates significant overall survival benefit in patients with EGFR-mutated advanced non-small cell lung cancer versus osimertinib
26/03/2025 -
PrimeBiome Reviews - Is it Worth Buying? Prime Biome Gummies Ingredients, Side Effects, and Investigative Report
26/03/2025 -
iTeos présentera les données précliniques d’EOS-215, un anticorps anti-TREM2 supposé meilleur de sa catégorie, et d’un nouvel inhibiteur de PTPN1/2 lors de l’édition 2025 du congrès annuel de l’American Association for Cancer Research
26/03/2025 -
OmegaX Health ($OmegaX) Expands to Binance Smart Chain – The Future of AI Healthcare on Blockchain
26/03/2025 -
Stryker announces intention to nominate Manny Maceda to board of directors
26/03/2025 -
Ivy En Rose Partners with Junior League of San Francisco for Exclusive Community Event on May 8, 2025
26/03/2025 -
FDA Recognizes Newly Revised AAMI Sterilization, Ethylene Oxide Guidance
26/03/2025 -
Best SARMs For Bulking, Cutting, Muscle Growth, Fat Loss Where to buy SARMs, Alternative Stack For Sale - CrazyBulk
26/03/2025 -
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
26/03/2025 -
Dr. Lyudmila Sarder Receives Prestigious U.S. Congressional Award for Women’s History Month
26/03/2025 -
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
26/03/2025 -
Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025
26/03/2025 -
Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider
26/03/2025 -
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
26/03/2025 -
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
26/03/2025 -
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
26/03/2025 -
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
26/03/2025
Pages